(Press-News.org) High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation. These are the significant findings from the large-scale international “FREEDOM” trial, led by Valentin Fuster, MD, PhD, President of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, and General Director of the Spanish National Center for Cardiovascular Research (CNIC).
The study results were announced Monday, March 6, in a Late Breaking Clinical Trial presentation at the American College of Cardiology Scientific Sessions Together with World Congress of Cardiology (ACC.23/WCC) in New Orleans and simultaneously published in the Journal of the American College of Cardiology.
“What we learned from this trial is that many patients hospitalized with COVID-19 with pulmonary involvement, but not yet in the intensive care unit (ICU), will benefit from high-dose subcutaneous enoxaparin or oral apixaban to inhibit thrombosis and the progression of the disease,” says Dr. Fuster. “This is the first study to show that high-dose anticoagulation may improve survival in this patient population—a major finding since COVID-19 deaths are still prevalent.”
This work was prompted by the discovery early in the pandemic that many patients hospitalized with COVID-19 developed high levels of life-threatening blood clots. Mount Sinai research showed that treatment with prophylactic (low-dose) anticoagulation was associated with improved outcomes both in and out of the intensive care unit among hospitalized COVID-19 patients. Researchers further observed that therapeutic (high-dose) anticoagulation might lead to better results. Then, they designed the FREEDOM COVID Anticoagulation Strategy Randomized Trial to look further into the most effective regimen and dosage for improving outcomes of hospitalized COVID-19 patients who are not critically ill.
Researchers enrolled 3,398 hospitalized adult patients with confirmed COVID-19 (median age 53) from 76 urban and rural hospitals across 10 countries—including hospitals within the Mount Sinai Health System in New York City—between August 26, 2020, and September 19, 2022. Patients were not in the ICU or intubated, and approximately half of them had signs of COVID-19 impacting their lungs with acute respiratory distress syndrome (ARDS). Patients were randomized to receive doses of three different types of anticoagulants within 24-48 hours of being admitted to the hospital and followed for 30 days. Equal numbers of patients were treated with one of three different drug regimens: prophylactic subcutaneous enoxaparin, therapeutic subcutaneous enoxaparin, and therapeutic oral apixaban. They compared the combined therapeutic groups to the prophylactic group.
The primary endpoint was a combination of death, requirement for ICU care, systemic thromboembolism, or ischemic stroke at 30 days. This endpoint was not significantly reduced between the groups. However, 30-day mortality was lower for those treated with therapeutic anticoagulation (high dose) compared with those on the prophylactic regimen (low dose). Seven percent of patients treated with the prophylactic anticoagulation died within 30 days compared with 4.9 percent of patients treated with therapeutic anticoagulation—an overall reduction of 30 percent. The need for intubations was also reduced in the therapeutic group: 6.4 percent of patients on the therapeutic regimen were intubated within 30 days compared with 8.4 percent in the prophylactic group—a 25 percent reduction. The study showed therapeutic anticoagulation to be especially beneficial for patients with ARDS, a condition where COVID-19 damages the lungs. Among patients with ARDS at the time of hospital admission, 12.3 percent in the prophylactic anticoagulation group died within 30 days compared with 7.9 in the therapeutic anticoagulation group.
All groups had low bleeding rates, and there were no differences between the two therapeutic blood thinners for safety and efficacy.
“This is an important study for patients with COVID-19 who are sick enough to require hospitalization but not so ill as to require ICU management. In this group of patients with radiologic evidence of ARDS, therapeutic dose anticoagulation prevents disease progression, especially the need for intubation, and saves lives. This is especially important as COVID-19 is not going away. Even in the United States, the current number of daily deaths, although much lower than at the peak of the pandemic, is twice that compared with just one year ago. And in other countries COVID-19 is raging,” says co-Principal Investigator Gregg W. Stone, MD, Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology), and Population Health Science and Policy, at Icahn Mount Sinai.
The FREEDOM COVID Anticoagulation Strategy Randomized Trial was coordinated by the Mount Sinai Heart Health System. Dr. Fuster raised all the funding for the trial.
Mount Sinai Heart is one of the world’s top hospitals in Cardiology/Heart Surgery
Mount Sinai Heart is among the top 6 in the nation for cardiology and cardiac surgery, according to U.S. News & World Report. Newsweek’s “The World’s Best Specialized Hospitals” ranks Mount Sinai Heart as No. 1 in New York and No. 4 globally.
It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 free-standing joint-venture centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked in U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and among the top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Urology, and Rehabilitation.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
###
END
High-dose anticoagulation can reduce intubations and improve survival for hospitalized COVID-19 patients
2023-03-06
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
ASBMB offers feedback on NIH’s proposed grant review framework
2023-03-06
After soliciting feedback from its members, the American Society for Biochemistry and Molecular Biology sent nine recommendations to the National Institutes of Health last week related to proposed changes to the research grant application peer-review process.
The society’s March 1 letter suggested:
Validating the proposed framework with a pilot study
Revamping the study section grant triage process
Conducting outreach before and during implementation
Using alternative criteria for certain types of projects
Moving forward with simplifying scored criteria and administrative document review
The NIH Office of Extramural Research ...
The marathon runners of the immune system
2023-03-06
When it comes to chronic infections and cancer, a particular type of immune cell plays a central role in our defenses. Researchers at the University of Basel have uncovered the key to the tenacity of these immune cells in coping with the marathon that is fighting a chronic infection. Their results lay the foundations for more effective therapies and vaccination strategies.
Infected and abnormal cells have to go. And as quickly as possible, before any more damage is done. This is the task of what are known as cytotoxic T cells. ...
A wholly sustainable plastics economy is feasible
2023-03-06
Plastic is everywhere. Our society cannot do without it: plastics have numerous advantages, are extremely versatile, and are also cost effective. Today, plastics are mainly produced from crude oil. When the products reach the end of their life, they often end up in a waste incineration plant. The energy-intensive production of plastics and their incineration release large amounts of CO2 into the atmosphere, making plastic products a major contributor to climate change.
One way out would be to rely on sustainable production methods, such as the circular economy, in which as much plastic as possible is recycled. Then the main raw material for ...
Graphene quantum dots show promise as novel magnetic field sensors
2023-03-06
Trapped electrons traveling in circular loops at extreme speeds inside graphene quantum dots are highly sensitive to external magnetic fields and could be used as novel magnetic field sensors with unique capabilities, according to a new study.
Electrons in graphene (an atomically thin form of carbon) behave as if they were massless, like photons, which are massless particles of light. Although graphene electrons do not move at the speed of light, they exhibit the same energy-momentum relationship as photons and can be described as “ultra-relativistic.” ...
Parental nonadherence to recommendations for COVID-19 prevention among children
2023-03-06
About The Study: In this survey study of U.S. parents, one-quarter engaged in misrepresentation or nonadherence regarding public health measures for their children. The most common reason was to preserve parental autonomy. Additional reasons included wanting to resume a normal life for their child and the inability to miss work or other responsibilities, among other reasons.
Authors: Andrea Gurmankin Levy, Ph.D., M.B.E., of Middlesex Community College in Middletown, Connecticut, is the corresponding author.
To access the embargoed study: Visit our ...
Mineral particles and their role in oxygenating the Earth’s atmosphere
2023-03-06
Mineral particles played a key role in raising oxygen levels in the Earth’s atmosphere billions of years ago, with major implications for the way intelligent life later evolved, according to new research.
Up to now, scientists have argued that oxygen levels rose as the result of photosynthesis by algae and plants in the sea, where oxygen was produced as a by-product and released into the atmosphere.
But a research ...
Two-dimensional quantum freeze
2023-03-06
Glass nanoparticles trapped by lasers in extreme vacuum are considered a promising platform for exploring the limits of the quantum world. Since the advent of quantum theory, the question at which sizes an object starts being described by the laws of quantum physics rather than the rules of classical physics has remained unanswered.
A team formed by Lukas Novotny (Zurich), Markus Aspelmeyer (Vienna), Oriol Romero-Isart (Innsbruck), and Romain Quidant (Zurich) is attempting to answer precisely this question within the ERC-Synergy project Q-Xtreme. A crucial step ...
Scientists twist chemical bonds beyond their limits
2023-03-06
A group of scientists from Durham University and University of York have twisted molecules to their breaking point in order to challenge the understanding of chemical bonds.
The researchers explored how far the chemical bonding in an aromatic ring can be twisted before its aromatic bonding breaks.
They achieved this by making overcrowded aromatic rings. Rather than benzene, they used tropylium, which shares electrons around a ring of seven carbon atoms.
Each of these carbon atoms can be functionalised and having seven attachment points in the ring, rather than the six carbon atoms of benzene, allowed ...
Siblings should be screened in cases of suspected child physical abuse
2023-03-06
Siblings of a child suspected of experiencing physical abuse should also be screened for abusive injuries, according to a new international consensus statement led by researchers at UCL (University College London) and Great Ormond Street Hospital for Children (GOSH).
The team of 27 researchers, from six different continents, are calling for a policy change to stop inconspicuous injuries being missed in contact children (i.e. siblings, cohabiting children, or children who are under the same care), and to help prevent further ...
Rewarding accuracy instead of partisan pandering reduces Republican-Democrat divide over the truth – study
2023-03-06
Offering a tiny cash reward for accuracy, or even briefly appealing to personal integrity, can increase people’s ability to tell the difference between misinformation and the truth, according to a new study.
The findings suggest that fake news thrives on social media not only because people are tricked into believing it, but also due to a motivational imbalance: users have more incentive to get clicks and likes than to spread accurate content.
Social psychologists from the University of Cambridge and New York University argue that their study, published in the journal ...